Article Details

Adcendo raises EUR 51 Million in Series A Financing to Advance Novel Antibody-Drug Conjugates ...

Retrieved on: 2021-04-29 06:56:15

Tags for this article:

Click the tags to see associated articles and topics

Adcendo raises EUR 51 Million in Series A Financing to Advance Novel Antibody-Drug Conjugates .... View article details on hiswai:

Excerpt

The Venture & Growth fund of Gilde Healthcare invests in innovative companies active in (Bio)Pharmaceuticals, HealthTech and MedTech. The portfolio ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up